Skip to content

Ketamine: all studies

Page 39 of 449: studies 381 to 390 of 4,483, newest first. Back to the ketamine overview

Research

Emerging Clinical Applications of Ketamine and Esketamine Across Psychiatric Disorders.

FOCUS: The Journal of Lifelong Learning in Psychiatry April 1, 2026 Rachel Fremont, Marcella Corwin, Greta Kandel et al.

Over the past 25 years, the field of psychiatry has seen a rapid expansion of ketamine treatment services offered for the off-label management of depression, anxiety, and other psychiatric disorders as well as the U.S. Food and Drug Administration's approval of intranasal esketamine, the S-enantiomer of ketamine, for treatment-resistant depression and suicidal depression. In this review, the...

Mangiferin Mitigates Ketamine-Induced Dopaminergic and Glial Dysregulation and Modulates Nrf2 Expression in a Rat Schizophrenia-Like Model

Journal of Experimental Pharmacology April 1, 2026 V. A. Chukwu, G. Anyanwu, N. Nto et al.

Introduction Schizophrenia involves dopaminergic dysregulation, oxidative stress, and glial activation within motor–cognitive circuits. Mangiferin, a polyphenolic C-glucoside from Mangifera indica, exerts antioxidant and anti-inflammatory effects partly via modulation of nuclear factor erythroid 2–related factor 2 (Nrf2) signaling. This study evaluated whether mangiferin attenuates...

Targeting beta-2 adrenergic receptor attenuates schizophrenia-like behavioral effects induced by ketamine in mice: cAMP/PKA/BDNF-PEA-3 and RIM-1α signaling pathways involvement

Saudi Pharmaceutical Journal April 1, 2026 Mohammed M. Heikal, Ahmed F. Mohamed, Nora O. Abdel Rasheed et al.

The interplay between cAMP/PKA and neuroplasticity involves intricate signaling pathways that are crucial for brain function and are frequently disrupted in schizophrenia. This study sought to examine the potential neuroprotective effects of formoterol on ketamine-induced schizophrenia-like behaviors with emphasis on several PKA downstream crucial targets for schizophrenia management. Male mice...

Caution Is Warranted in Prescribing Ketamine for Mental Health.

Journal of General Internal Medicine April 1, 2026 Katherine Drabiak 2 citations

Clinics across the USA advertise ketamine as an alternative solution for mental health conditions. Ketamine has expanded into a multibillion-dollar industry, with three delivery models: (1) in-person clinics offering off-label racemic ketamine; (2) clinic visits for esketamine (Spravato); and (3) telehealth services prescribing off-label racemic ketamine. About half of the market encompasses...

Concurrent assessment of neurometabolism and brain hemodynamics to characterize the functional brain response to psychotropic drugs: An S-ketamine study.

Journal of Cerebral Blood Flow & Metabolism April 1, 2026 Daphne E Boucherie, Liesbeth Reneman, Jan Booij et al.

Neuroimaging techniques offer valuable insights for understanding pharmacological treatment effects in neuropsychiatric disorders. Here, we present a novel approach that simultaneously assesses hemodynamic and neurometabolic brain responses to psychotropic drugs using interleaved pharmacological magnetic resonance imaging (phMRI) and pharmacological magnetic resonance spectroscopy (phMRS). This...

Biological variations in ketamine sensitivity: insights from hyperlocomotion to psychotomimetic features in genetically diverse mouse strains.

Psychiatry Research April 1, 2026 Wen-Huei Siao, Tzong-Shi Wang, Liang-Chun Wang et al.

Ketamine, a non-competitive NMDA receptor antagonist, induces dissociative and psychotomimetic states and is widely used as an animal model for schizophrenia. However, strain-dependent variability in ketamine sensitivity is poorly understood, especially during adolescence, a developmental period marked by heightened vulnerability to NMDA receptor hypofunction. This study would compare...

DOI: 10.1016/j.psychres.2026.116995 (opens in new tab) Full text (opens in new tab) Animal model Genetic diversity Ketamine sensitivity Nmda receptor hypofunction +1

Sub-Anesthetic Ketamine Administration Decreases Deviance Detection Responses at the Cellular, Population- and Mesoscale Levels.

European Journal of Neuroscience April 1, 2026 Maria Isabel Carreño-muñoz, Alessandra Ciancone Chama, Pegah Chehrazi et al.

In the neocortex, neuronal processing of sensory events is significantly influenced by their predictability. A common example is the suppression of responses to repetitive stimuli in sensory cortices, a phenomenon known as habituation. Within a sensory information stream, whenever a novel stimulus deviates from expectations, enhanced brain responses are observed. Mismatch negativity (MMN), the...

DOI: 10.1111/ejn.70471 (opens in new tab) Full text (opens in new tab) Ketamine Auditory Deviance detection Mismatch negativity +2

Comparative EEG analysis of the effects of ketamine enantiomers and metabolites in rhesus macaques.

Journal of Neurophysiology April 1, 2026 Yoshihiro Iwamura, Kantaro Nishigori, Masataka Yamaguchi et al.

(R,S)-Ketamine, a dissociative anesthetic, has shown rapid and sustained antidepressant effects at lower doses than those required for anesthetic effects in patients with treatment-resistant depression. However, its use is limited because it causes side effects, including psychotomimetic symptoms and dependence. The enantiomer (R)-ketamine was reported to promote antidepressant-like effects in...

DOI: 10.1152/jn.00203.2025 (opens in new tab) Full text (opens in new tab) Electroencephalography Ketamine enantiomers Ketamine metabolites Rhesus monkey

Effect of Perioperative Ketamine on Early Postpartum Depressive Symptoms Following Cesarean Section: A Meta-Analysis.

Cureus April 1, 2026 Samantha Siu, Peter Hsin, Sarah Simon et al.

Postpartum depression (PPD) is a common condition associated with adverse maternal and infant outcomes. Higher rates have been observed following cesarean delivery, prompting interest in perioperative preventive strategies. Ketamine has demonstrated rapid antidepressant effects and may provide psychiatric benefits beyond analgesia. We conducted a systematic review and meta-analysis of...

DOI: 10.7759/cureus.107180 (opens in new tab) Full text (opens in new tab) Esketamine Cesarean ​section Meta-analysis Peri-operative medicine +1

Ketamine as a potential cognitive enhancer in neurological disorders: evidence from preclinical and clinical studies

Frontiers in Neurology March 30, 2026 Jose E. Leon-Rojas, Guido Mascialino, Lizeth Vinueza Mera et al. 2 citations

Subanesthetic ketamine shows rapid neuroplastic and antidepressant effects in psychiatric conditions, prompting interest in its potential relevance for cognitive dysfunction in neurological disorders. Cognitive deficits are widespread across traumatic brain injury, stroke, epilepsy, and neurodegenerative diseases, yet treatments remain primarily compensatory. Ketamine's actions on glutamatergic...